✦ LIBER ✦

Deleterious effects of intravenous immunoglobulin in a patient with thrombotic thrombocytopenic purpura

✍ Scribed by Jean Marc Durand; Patrice Lefevre; Gilles Kaplanski; Frederique Retornaz; Elodie Cretel; Jacques Soubeyrand

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 258 KB
Volume: 44
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830440321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inefficacy of intravenous immunoglobulin

Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome

✍ Dr. Guido Finazzi; Piero Bellavita; Anna Falanga; Piera Viero; Tiziano Barbui 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Thrombotic thrombocytopenic purpura in a

Thrombotic thrombocytopenic purpura in a patient with Behçet's disease

✍ Fadi I. Jabr; Ali Shamseddine; Imad Uthman; Aref Chehal; Ali Taher 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Fatal thrombotic thrombocytopenic purpur

Fatal thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus

✍ Fred A. Cecere; Sadyoshi Yoshinoya; Richard M. Pope 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

## Abstract An immunologic mechanism, possibly immune complex mediated, has been suggested as the basis for the pathogenesis of thrombotic thrombocytopenic purpura (TTP). The evidence supporting this concept has been the association of TTP with systemic lupus erythematosus and the successful therap

Cellular source of serum lactate dehydro

Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura

✍ Jill A. Cohen; Mark E. Brecher; Nicholas Bandarenko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

Elevated serum lactate dehydrogenase (LDH) is a characteristic finding in patients with thrombotic thrombocytopenic purpura (TTP). It is widely accepted that total serum LDH principally rises due to the release of red blood cell LDH as a consequence of intravascular hemolysis. To identify the cellu

Effect of prophylactic cyclosporine ther

Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura

✍ Spero R. Cataland; Ming Jin; Shili Lin; Eric H. Kraut; James N. George; Haifeng 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d